Tiziana Life Sciences Ltd
TLSA · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $88 | $61 | $126 | $41 |
| Gross Profit | -$88 | -$61 | -$126 | -$41 |
| % Margin | – | – | – | – |
| R&D Expenses | $3,243 | $2,653 | $5,152 | $4,826 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5,625 | $6,479 | $7,608 | $1,366 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8,868 | $9,132 | $12,760 | $6,192 |
| Operating Income | -$8,956 | -$9,193 | -$12,886 | -$6,233 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $3,324 | $427 | -$3,074 | -$2,392 |
| Pre-Tax Income | -$5,632 | -$8,766 | -$15,960 | -$8,625 |
| Tax Expense | $0 | -$1,557 | -$6,652 | $449 |
| Net Income | -$5,632 | -$7,209 | -$9,308 | -$9,074 |
| % Margin | – | – | – | – |
| EPS | -0.096 | -0.13 | -0.18 | -0.18 |
| % Growth | 25.8% | 27.8% | 0% | – |
| EPS Diluted | -0.096 | -0.13 | -0.18 | -0.18 |
| Weighted Avg Shares Out | 58,413 | 54,557 | 51,549 | 51,330 |
| Weighted Avg Shares Out Dil | 58,413 | 54,557 | 51,549 | 51,330 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $702 | $224 | $1,154 |
| Interest Expense | $0 | $6 | $0 | $5 |
| Depreciation & Amortization | $88 | $61 | $126 | $41 |
| EBITDA | -$5,544 | -$8,699 | -$15,834 | -$8,579 |
| % Margin | – | – | – | – |